Literature DB >> 11099148

Computerized electronystagmography: normative data revisited.

A Van Der Stappen1, F L Wuyts, P H Van De Heyning.   

Abstract

This study provides normative data from computerized electronystagmography (ENG) testing of 40 healthy subjects with an average age of 45 years. The clinical test protocol comprises an extensive vestibular examination with oculomotor, positional, rotary chair and caloric tests. The results show that with a computerized ENG set-up considerable variabilities of 22% for rotary chair asymmetry and 19% for caloric labyrinth asymmetry remain.

Mesh:

Year:  2000        PMID: 11099148     DOI: 10.1080/000164800750000243

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  15 in total

1.  Worldwide survey on laboratory testing of vestibular function.

Authors:  Michael Strupp; Joy Grimberg; Julian Teufel; Göran Laurell; Herman Kingma; Eva Grill
Journal:  Neurol Clin Pract       Date:  2020-10

2.  Presbyvestibulopathy: Diagnostic criteria Consensus document of the classification committee of the Bárány Society.

Authors:  Yuri Agrawal; Raymond Van de Berg; Floris Wuyts; Leif Walther; Mans Magnusson; Esther Oh; Margaret Sharpe; Michael Strupp
Journal:  J Vestib Res       Date:  2019       Impact factor: 2.354

3.  The Impact of Dizziness on the Quality of Life of 235 Individuals who Completed Vestibular Testing in Brazil.

Authors:  Najlla Lopes de Oliveira Burle; Ana Célia Pereira de Abreu; Juliana Nunes Santos; Patricia Cotta Mancini
Journal:  Int Arch Otorhinolaryngol       Date:  2015-07-16

4.  Cognitive Function in Acquired Bilateral Vestibulopathy: A Cross-Sectional Study on Cognition, Hearing, and Vestibular Loss.

Authors:  Bieke Dobbels; Griet Mertens; Annick Gilles; Annes Claes; Julie Moyaert; Raymond van de Berg; Paul Van de Heyning; Olivier Vanderveken; Vincent Van Rompaey
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

5.  Paving the Way Toward Distinguishing Fallers From Non-fallers in Bilateral Vestibulopathy: A Wide Pilot Observation.

Authors:  Nolan Herssens; Bieke Dobbels; Julie Moyaert; Raymond Van de Berg; Wim Saeys; Ann Hallemans; Luc Vereeck; Vincent Van Rompaey
Journal:  Front Neurol       Date:  2021-03-01       Impact factor: 4.003

6.  Semicircular Canal Fibrosis as a Biomarker for Lateral Semicircular Canal Function Loss.

Authors:  Vincent Van Rompaey; Frank De Belder; Paul Parizel; Paul Van de Heyning
Journal:  Front Neurol       Date:  2016-03-23       Impact factor: 4.003

7.  Bilateral Vestibular Hypofunction: Insights in Etiologies, Clinical Subtypes, and Diagnostics.

Authors:  F Lucieer; P Vonk; N Guinand; R Stokroos; H Kingma; Raymond van de Berg
Journal:  Front Neurol       Date:  2016-03-04       Impact factor: 4.003

8.  Playing Music May Improve the Gait Pattern in Patients with Bilateral Caloric Areflexia Wearing a Cochlear Implant: Results from a Pilot Study.

Authors:  Ann Hallemans; Griet Mertens; Paul Van de Heyning; Vincent Van Rompaey
Journal:  Front Neurol       Date:  2017-08-17       Impact factor: 4.003

9.  Prospective cohort study on the predictors of fall risk in 119 patients with bilateral vestibulopathy.

Authors:  Bieke Dobbels; Florence Lucieer; Griet Mertens; Annick Gilles; Julie Moyaert; Paul van de Heyning; Nils Guinand; Angelica Pérez Fornos; Nolan Herssens; Ann Hallemans; Luc Vereeck; Olivier Vanderveken; Vincent Van Rompaey; Raymond van de Berg
Journal:  PLoS One       Date:  2020-03-09       Impact factor: 3.240

10.  Genotype-Phenotype Correlation Study in a Large Series of Patients Carrying the p.Pro51Ser (p.P51S) Variant in COCH (DFNA9) Part II: A Prospective Cross-Sectional Study of the Vestibular Phenotype in 111 Carriers.

Authors:  Sebastien P F JanssensdeVarebeke; Julie Moyaert; Erik Fransen; Britt Bulen; Celine Neesen; Katrien Devroye; Raymond van de Berg; Ronald J E Pennings; Vedat Topsakal; Olivier Vanderveken; Guy Van Camp; Vincent Van Rompaey
Journal:  Ear Hear       Date:  2021 Nov-Dec 01       Impact factor: 3.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.